Taro Pharmaceutical Industries Shares Close in on 52-Week Low - Market Mover
The shares closed 0.6% above its 52-week low of $52.61, with trading volume higher than its 30 day average
Nov 27, 2021 by Kwhen Finance Editors
Taro Pharmaceutical Industries (TARO) shares closed today at 0.6% above its 52 week low of $52.61, giving the company a market cap of $1B. The stock is currently down 27.8% year-to-date, down 22.7% over the past 12 months, and down 43.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 0.1%.
Trading Activity
- Trading volume this week was 23.7% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.6.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|
Taro Pharmaceutical Industries | -0.2 | -27.8 | -22.7 | -33.6 | 1.0 |
Dow Jones Industrial Average | -2.5 | 18.8 | 21.9 | -4.0 | 20.9 |
S&P 500 Index | -2.2 | 26.8 | 31.3 | -2.3 | 30.6 |
Health Care | -0.5 | 16.8 | 23.1 | -3.2 | 23.2 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -426.9%
- The company's stock price performance over the past 12 months lags the peer average by -299.8%
Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|---|
Taro Pharmaceutical Industries | TARO | 0 | -27.8 | -22.7 | -33.6 | 1.0 |
Peer Avg | N/A | 21.9 | 8.5 | 11.4 | -12.7 | 89.2 |
Johnson & Johnson | JNJ | 23.6 | 4.4 | 14.3 | -9.7 | 15.1 |
Pfizer Inc. | PFE | 14.9 | 43.7 | 44.8 | 2.2 | 66.4 |
Merck & Co Inc | MRK | 28.9 | 3.3 | 6.3 | -14.0 | 422.2 |
Novartis AG - ADR | NVS | 34.6 | -9.8 | -4.5 | -14.7 | 0.2 |
Glaxosmithkline plc - ADR | GSK | 16.1 | 19.6 | 18.2 | -4.3 | 27.8 |
Teva- Pharmaceutical Industries Ltd. - ADR | TEVA | 13.2 | -10.1 | -11.0 | -35.7 | 3.8 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: